HCA Healthcare (HCA) Stock Analysis & AI Equity Report

Medical - Equipment & Services USD Explore free reports

HCA Healthcare (HCA) overview

HCA Healthcare (HCA) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 75,600m and operating profit of USD 12,002m; the year-end share price was 466.86 USD and market capitalisation was USD 104,859m. HCA Healthcare is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get HCA Healthcare's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD -6,027mFY 2025
Share price466.86 USDFY 2025 year end
RevenueUSD 75,600mFY 2025
Operating profitUSD 12,002mFY 2025
Net earningsUSD 6,784mFY 2025
Market capitalisationUSD 104,859mFY 2025 year end

About HCA Healthcare

HCA Healthcare operates general acute care, behavioral and rehabilitation hospitals, along with ambulatory surgery centers and endoscopy centers. Its facilities provide medical and surgical specialties, diagnostic and emergency care, mental health services, rehabilitation, and outpatient and ancillary services. The company serves patients and communities through hospitals, physician practices, urgent care facilities, clinics, diagnostic centers and home health and hospice services.

Generate the HCA Healthcare report

HCA Healthcare is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for HCA Healthcare and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on HCA Healthcare

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.